About Aarmed Formulations Private Limited
Data last updated:
Aarmed Formulations Private Limited is a private limited company based in Gorakhpur, Uttar Pradesh, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 03 January 2000 and has been in existence for over 26 years.
The company is registered with the Registrar of Companies (ROC), Kanpur, under CIN U24231UP2000PTC025014. Its GSTIN is 24AAECA8398L1Z4 (Gujarat).
The company has an authorised share capital of ₹1 Cr and a paid-up capital of ₹97.16 Lakh. It is led by directors Jyoti Kumar Agrawal and Pooja Agrawal.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at C/O Sri Aatma Ram Kasia Road, Gorakhpur, Uttar Pradesh, India – 273001.
As per the financials filed for FY 2025, the company reported a revenue of ₹38.12 Cr, a growth of 62% compared to the previous year. For the same year it recorded a net profit of ₹3.23 Cr (net margin 8.5%) and EBITDA of ₹6.43 Cr (EBITDA margin 16.9%). Revenue has grown at a compounded annual rate (CAGR) of 1% over three years and 15% over five years.
The company has about 14 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: Aarmed Formulations. As per MCA filings, the company has open charges of ₹13.5 Cr on record. Court records list 9 cases involving the company, including 3 filed by the company and 5 filed against it; 4 cases are pending.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website aarmedformulations.com.
- EmailLocked
- TelephoneLocked
- Website
- Social MediaLocked
- Registered AddressC/O Sri Aatma Ram Kasia Road, Gorakhpur, Uttar Pradesh, India – 273001
- IndustryPharma, Drug Formulation & Development
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Associated Brands with Aarmed Formulations Private Limited
Aarmed Formulations operates one associated brand: Aarmed Formulations. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Probiotic manufacturing, vitamin supplements, and pharmaceutical services in India. | aarmedformulations.com |
Business Activity of Aarmed Formulations Private Limited
The main business activity of Aarmed Formulations is trade. In detail, this covers retail trading.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| G | Trade | G2 | Retail Trading | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Aarmed Formulations Private Limited FY 2025 filings available
Aarmed Formulations Private Limited reported revenue of ₹38.12 Cr (up 62% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR) of Aarmed Formulations Private Limited
Revenue has grown at a compounded annual rate (CAGR) of 15% over five years, including 62% growth in the latest year. EBITDA rose 21% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Aarmed Formulations Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹6.43 Cr | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹3.23 Cr | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Aarmed Formulations Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 16.9% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 8.5% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Aarmed Formulations are in the company report.
Financial statements from 2015
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Board of Directors of Aarmed Formulations Private Limited
Aarmed Formulations has 2 current directors and 3 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Jyoti Kumar Agrawal Also directs: Aarmed Bio-Science Private Limited, Bug Buddy Private Limited | Director | 03 Jan 2000 | 26 Years 9 Months | Current |
| Pooja Agrawal Also directs: Bug Buddy Private Limited | Director | 08 Feb 2021 | 5 Years 8 Months | Current |
Peer Comparison of Aarmed Formulations Private Limited
Aarmed Formulations Private Limited is compared with the companies closest to it by revenue in the Healthcare industry (Formulations, Preventive Healthcare Supplements). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Aavishkar Oral Strips Private Limited | ₹38.34 Cr (FY 2024) | •••• | •••• | 45.0% | •••• | Kothur, Telangana, India |
| Bio Medica Laboratories Limited | ₹38.33 Cr (FY 2025) | •••• | •••• | 150.0% | •••• | Indore, Madhya Pradesh, India |
| Medicamen Organics Limited. | ₹38.28 Cr (FY 2025) | •••• | •••• | 51.0% | •••• | New Delhi, Delhi, India |
| Diamond Drugs Private Limited | ₹38.26 Cr (FY 2024) | •••• | •••• | 2.0% | •••• | Kolkata, West Bengal, India |
| Klar Sehen Pvt Ltd | ₹38.16 Cr (FY 2016) | •••• | •••• | 18.0% | •••• | Bidar, Karnataka, India |
| Aarmed Formulations Private Limited this company | ₹38.12 Cr (FY 2025) | •••• | •••• | 62.0% | •••• | Gorakhpur, Uttar Pradesh, India |
| Tulip Lab Private Limited | ₹38.12 Cr (FY 2023) | •••• | •••• | -78.0% | •••• | Mumbai, Maharashtra, India |
| Biomax Biotechnics Private Limited | ₹38.1 Cr (FY 2025) | •••• | •••• | 9.0% | •••• | Chandigarh, India |
| Avanscure Lifesciences Private Limited | ₹38.07 Cr (FY 2025) | •••• | •••• | -26.0% | •••• | Bareilly, Uttar Pradesh, India |
| Zivira Labs Private Limited | ₹38.07 Cr (FY 2025) | •••• | •••• | 22.0% | •••• | Mumbai, Maharashtra, India |
| VVR Organics Private Limited | ₹38.01 Cr (FY 2024) | •••• | •••• | 9.0% | •••• | Hyderabad, Telangana, India |
Peers are the five companies nearest above and the five nearest below Aarmed Formulations by revenue in the Healthcare industry (Formulations, Preventive Healthcare Supplements), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Aarmed Formulations Private Limited
Aarmed Formulations Private Limited is audited by VIJAY MOONDRA &CO. for the financial year 2024.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| VIJAY MOONDRA &CO. | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Ownership and Shareholding of Aarmed Formulations Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Aarmed Formulations Private Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 13 Oct 2025 | Others | ₹1.01 Cr | Open |
| 11 Jul 2025 | Others | ₹1.01 Cr | Open |
| 02 Jul 2025 | Others | ₹35 Lakh | Open |
| 22 Nov 2019 | Others | ₹10.48 Cr | Open |
| 03 Oct 2016 | Others | ₹66 Lakh | Open |
Total charge records: 5 View all charges
Legal Cases of Aarmed Formulations Private Limited
Aarmed Formulations Private Limited has 9 court cases on record: 3 filed by Aarmed Formulations, 5 filed against it, 1 where it is another party. 4 cases are pending and 5 are disposed. Status as checked between 02 Oct 2026 and 04 Oct 2026.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 8 | 5 | 3 |
| High courts | 1 | 0 | 1 |
Cases on record (5 of 9)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Faridabad, Haryana | Commercial suit | Filed against the company by Petplast Packaging Private Limited | Pending |
| District court, Ahmedabad, Gujarat | Criminal complaint | Filed by the company against Necs Pharma LLP | Pending |
| District court, Ahmedabad, Gujarat | Court case (CR EN) | Filed by the company against Necs Pharma LLP | Disposed |
| High Court of Uttarakhand | Court case (WPCRL) | Filed by the company against State of Uttarakhand | Pending |
| District court, Tiruvannamalai, Tamil Nadu | Criminal complaint | Company is another party | Pending |
Full case history
All 9 cases with case numbers, court, year-wise trend, opposite parties and decision dates are in the company report.
- Every case with its case number
- Year-wise trend
- Opposite parties
- Decision dates and orders
Verified entity values are shown only after access is granted.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
Employees and EPFO Compliance at Aarmed Formulations Private Limited
Aarmed Formulations Private Limited has a workforce of 14 employees as of Apr 06, 2024.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Aarmed Formulations Private Limited
Aarmed Formulations Private Limited has 5 board changes on record since 2000: 2 appointments and 3 cessations. The latest: Atma Ram Agrawal ceased to be Director on 08 Feb 2021.
2 earlier events are listed in the company report.
Credit Ratings, Litigation & Regulatory Alerts for Aarmed Formulations Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Aarmed Formulations Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Aarmed Formulations Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Aarmed Formulations Private Limited
Aarmed Formulations has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 24AAECA8398L1Z4 | Gujarat | Active | 01 Jul 2017 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Aarmed Formulations Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Aarmed Formulations Private Limited
Aarmed Formulations is an active private limited company based in Gorakhpur, Uttar Pradesh, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 03 January 2000 (26+ years old) and is registered under CIN U24231UP2000PTC025014.
Aarmed Formulations reported revenue of ₹38.12 Cr for FY 2025 (up 62% YoY).
Aarmed Formulations has 2 current directors:
- Jyoti Kumar Agrawal - Director
- Pooja Agrawal - Director
Aarmed Formulations reported a net profit of ₹3.23 Cr (net margin 8.5%) and EBITDA of ₹6.43 Cr (EBITDA margin 16.9%) for FY 2025, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Aarmed Formulations is 1% over three years and 15% over five years. In the latest year (FY 2025) revenue rose 62%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Aarmed Formulations is 24AAECA8398L1Z4, registered in Gujarat.
The CIN (Corporate Identification Number) of Aarmed Formulations is U24231UP2000PTC025014. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Aarmed Formulations has 9 court cases on record: 3 filed by the company and 5 filed against it. 4 are pending. Most are in the district courts.
Aarmed Formulations was incorporated on 03 January 2000, making it 26+ years old. It is registered with the Registrar of Companies, Kanpur.
The peers of Aarmed Formulations by revenue are Aavishkar Oral Strips Private Limited, Bio Medica Laboratories Limited, Medicamen Organics Limited, Diamond Drugs Private Limited, Klar Sehen Pvt Ltd and 5 more, all in the Healthcare industry (Formulations, Preventive Healthcare Supplements).
Atma Ram Agrawal ceased to be Director on 08 Feb 2021. Pooja Agrawal was appointed as Director on 08 Feb 2021. Ritu Devi Agrawal ceased to be Director on 01 Jun 2013. Aarmed Formulations has 5 board changes on record in total.